March 14, 2007 18:21 ET

Ceapro to Present at Investor Conference

EDMONTON, ALBERTA--(CCNMatthews - March 14, 2007) - Ceapro Inc. (TSX VENTURE:CZO) today announced that Mark Redmond, Ph.D., President and Chief Executive Officer, is scheduled to present at the InformedInvestors.com webcast on Thursday March 15, 2007 at 11.30 EST.

As an investment, Ceapro offers shareholders the following benefits:

- a growing base of revenues based on proprietary active ingredients and long-standing distribution partnerships;

- important new technology and products poised to enter markets demonstrated to be receptive for the technology;

- important technology in development in the fields of therapeutics, drug-delivery, and bioenergy.

To join the broadcast log-on to www.vcall.com/EventPage.asp?ID=114819. If you are unable to participate during the live webcast, the call will be available for replay at www.vcall.com/ClientPage.asp?ID=114819 or http://www.investorcalendar.com/

About Ceapro Inc.

Ceapro Inc is a Canadian growth-stage biotechnology company. Ceapro's core technology is the extraction of functional, active ingredients from plants and other renewable resources. We add further value to our extracts by manufacturing medical and therapeutic products, and by supporting the use of our extracts in products for human and animal health. We have also introduced health and wellness services employing our CeaProve® diagnostic technology. Our most recent initiative is the creation of Ceapro BioEnergy Inc. (CBE), a wholly-owned subsidiary to utilize Ceapro's proprietary technology for the production of ethanol and value-added products. Ceapro shares trade on the Canadian TSX Venture Exchange under the symbol CZO. To learn more about Ceapro, visit our website at www.ceapro.com.

Contact Information

  • Ceapro Inc.
    Dr. Mark Redmond
    President and CEO
    (Edmonton): (780) 421-4555
    Wesbite: www.ceapro.com
    Sun International Communications
    Nicole Blanchard, B.Sc., B.Comm.
    Managing Partner
    (Montreal): (450) 627-6600